Lumos Diagnostics Holdings (ASX:LDX) opened the retail component of its one-for-1.82 accelerated non-renounceable pro-rata entitlement offer, according to a filing with the Australian bourse.
The offer has an issue price of AU$0.038 per share, with about 264.5 million new shares to be issued.
It is led, managed, and underwritten by Bell Potter Securities up to AU$6.1 million.
The offer will close on Oct. 2.
The diagnostic test technology company's shares were down more than 5% in recent Wednesday trade.
Price (AUD): $0.04, Change: $-0.0020, Percent Change: -5.41%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments